Science & Tech · AI · 2 hrs ago
South Korean drugmakers look to AI and wearables for digital health
South Korean drug and biotech companies are turning to digital health as they look for new areas of growth.
The tools include AI that estimates risks such as blindness and heart failure.
Wearable devices can also track signals such as heart rate and breathing.
The move comes as an ageing population increases demand for health care and monitoring.
Digital tools could help companies respond to that demand, though the text gives no details about their use or results.
The companies are exploring digital health as a potential growth area, but no next steps are specified.
South Korean pharmaceutical and biotechnology companies are focusing on digital health care.
The technologies include AI that predicts risks of blindness and heart failure.
Wearable devices can detect measures such as heart rate and breathing.
Companies are seeking new sources of growth as demand for health management rises with an aging population.
- Who
- South Korean pharmaceutical and biotechnology companies, including Daewoong Pharmaceutical.
- What
- They are focusing on digital health care, including AI risk prediction and wearable monitoring.
- When
- The article was published on November 6, 2026.
- Where
- South Korea.
- Why
- Demand for health management is rising as the population ages, and companies are seeking new growth drivers.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Companies
- South Korean pharmaceutical and biotechnology firms
- AI applications
- Predicting risks of blindness and heart failure
- Wearable measurements
- Heart rate and breathing
- Company named
- Daewoong Pharmaceutical
- Article publication
- November 6, 2026